ArticleBMC cancer2026

Combining tertiary lymphoid structures and tumor stroma percentage for predicting prognosis and chemotherapy benefits in stage II-III colorectal cancer.

Kun Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.